Patents

Guylène Kiesel Le Cosquer, Ina Schreiber
Trademarks & Designs, Patents
Plasseraud IP à l’APAA 2025 à Kuala Lumpur
Our experts, Guylène Kiesel Le Cosquer, Partner and Board Member, and Ina Schreiber, Partner and (...)
Denis Bourgarel, Nathalie Wajs
Patents, Biology Chemistry
Ipsen announces its intention to acquire ImCheck Therapeutics
On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a (...)
Patents
Quatre experts de Plasseraud IP distingués parmi les meilleurs dans IAM Global Leaders 2026
Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina (...)
Park Seowon, Girard Vincent
Patents
Plasseraud IP at the Osong Cosmetics & Beauty Expo 2025 in South Korea
On October 23, 2025, Vincent Girard and Seowon PARK, experts at Plasseraud IP, represented the (...)
Cyra Nargolwalla, Nadine Rocaboy
Patents
Cyra Nargolwalla and Nadine Rocaboy have been recognized in the IAM Strategy 300 and IAM Strategy 300 Global Leaders 2025 rankings
The IAM Strategy 300: The World’s Leading IP Strategists identifies professionals who stand out for (...)
Trademarks & Designs, Patents, Avocats
Plasseraud IP au cœur des enjeux de la PI mondiale - Rendez-vous à Yokohama pour l’AIPPI World Congress 2025
Guylène Kiesel Le Cosquer, Laurence Loumes, Atsuya Takeshita, Atom Tong, Partners, Isabelle Labarre (...)
Charlotte Montaud, Nathalie Wajs
Patents, Biology Chemistry
Plasseraud IP at the 7th edition of the Sustainable Leather Forum on September 8, 2025 at Maison de la Chimie, Paris
This year, Charlotte Montaud-Chanial (Partner, Contracts, Audit and Valuation Practice Group (...)
Patents
Looking back at the UN Citiverse Challenge 2025
Plasseraud IP took part in the inaugural UN Citiverse Challenge, organized by the United Nations (...)
Béatrice Aveline, Nadine Rocaboy
Patents
Brevets Américains : nouvelle taxe supplémentaire pour les demandes de brevets ultérieures devant l’USPTO
Since January 19, 2025, filing a continuing patent application (continuation, divisional, or (...)
Lilia Leghmizi
Patents
On 27 June 2023, in case T 438/19, Technical Board 3.3.03 referred key questions to the Enlarged (...)
Denis Bourgarel, Anna-Lila Kaushik
Patents
Levée de fonds de 135 millions USD pour notre client SpliceBio
Founded in September 2012, SpliceBio is a clinical-stage genetic medicine company pioneering (...)
Bruno Loubet
Patents
T 1580/23 : la seule mention d'une norme de télécommunication dans la description d'un brevet européen ne suffit pas à revendiquer un effet relatif à la mise en œuvre de la norme
The decision T 1580/23 of the Boards of Appeal 3.5.05 of the European Patent Office (EPO) is an (...)